Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Net Income From Continuing Operations : $-8.95 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Harvard Apparatus Regenerative Technology Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Harvard Apparatus Regenerative Technology's net income from continuing operations for the three months ended in Dec. 2023 was $-1.83 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.95 Mil.

Harvard Apparatus Regenerative Technology Net Income From Continuing Operations Historical Data

The historical data trend for Harvard Apparatus Regenerative Technology's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Apparatus Regenerative Technology Net Income From Continuing Operations Chart

Harvard Apparatus Regenerative Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-8.33

-4.87

-7.98

-6.07

-8.95

Harvard Apparatus Regenerative Technology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-1.50	-2.89	-2.61	-1.62	-1.83

Harvard Apparatus Regenerative Technology Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.95 Mil.

Harvard Apparatus Regenerative Technology (Harvard Apparatus Regenerative Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Harvard Apparatus Regenerative Technology Inc (OTCPK:HRGN) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

84 October Hill Road, Suite 11, Holliston, MA, USA, 01746

Website

https://www.biostage.com

Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects. The company's technology is based on its proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs.

Executives

Junli He	director	C/O NO.1, COUNTRY GARDEN ROAD, BEIJIAO TOWN, SHUNDE DISTRICT, FOSHAN F4 528300
James E. Shmerling	director	975 JOHNSON FERRY ROAD, SUITE 450, ATLANTA GA 30342
Dst Capital Llc	10 percent owner	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ronald J Packard	director	2300 CORPORATE PARK DRIVE, HERNDON VA 20171
Jing Chen	director	C/O BIOSTAGE,INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 02110
Hong Yu	officer: President	C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Damasio Joseph Luis Jr	officer: Chief Financial Officer	14 NORFOLK AVENUE, SOUTH EASTON MA 02375
David Green	director, officer: See Remarks	C/O HARVARD BIOSCIENCE INC, 84 OCTOBER HILL ROAD, HOLLISTON MA 01746-1371
William Fodor	officer: Chief Scientific Officer	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Peter A. Pellegrino	officer: Interim VP of Finance	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Herman Sanchez	director	84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746
James Mastridge	officer: See Remarks	C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746
Jeffrey E Young	director	60 WESTVIEW STREET, LEXINGTON MA 02421
Wei Zhang	director	C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Ting Li	director	C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746